Bibliographic information
Recommendation
For the clinical rehabilitation management of post-exertional symptom exacerbation (PESE), in adults with post COVID-19 condition we suggest using education and skills training on energy conservation techniques such as pacing approaches. The provision and training in the use of assistve products and environmental modifcations may be useful for people experiencing moderate to severe PESE.
Recommended in favor
Conditional
Notes and Remarks
Practical Info Evidence-based questionnaires and screening tools (343)(346)(347)(348)(349)(350), and patient-reported outcome measures (351)(352), can be used to identify, assess, and monitor interventions for PESE. Post-exertional symptom exacerbation may not be mentioned spontaneously by individuals, due to unfamiliarity with the concept (346). Clinicians should carefully assess for PESE in post COVID-19 condition, including PESE symptoms, triggers, duration, and change over time (350), while ruling out activity intolerance or reduced exercise tolerance which may be caused by respiratory, cardiovascular, and musculoskeletal conditions (293)(322)(353). Activity and energy management, or pacing, should be flexible, balancing activities and rest contingent on symptoms (293). Pacing is itself a complex and active intervention, where physical and cognitive exertion, including over exertion, can be triggers for post COVID-19 condition symptom exacerbation or relapse (329)(354)(355)(356). Sustained symptom stabilization may suggest positive effects of pacing, and stability (e.g. 1 month) should be achieved before attempting to modify or increase activities (293). Help patients to identify the timing to safely resume progressive and adapted physical activities. Interventions for rehabilitation based on fixed incremental increases in the time spent being physically active or graded exercise, should not be offered to people experiencing PESE (340). Careful monitoring of symptoms over time can help identify symptom improvements, potential recovery, flare-ups, or relapses.
Also Featured In
This recommendation also appears in the following guidelines:
Clinical management of COVID-19: living guideline, 13 January 2023.
Clinical management of COVID-19: living guideline, 18 August 2023
Clinical management of COVID-19: living guideline, June 2025